West Pharmaceutical Services explosion

Element drives global life science strategy with appointment of industry expert Dr. Elisabeth Lackner as Chief Scientific Officer

Retrieved on: 
Thursday, June 30, 2022
Environmental monitoring, Calibration, LinkedIn, West Pharmaceutical Services explosion, University, Operation Board Games, Research, Technology, EMC, CEO, GLOBE, ESG, Laboratory, Growth, Failure, Pharma, Â, Testing, inspection and certification, Microbiology, Industry, CSO, CRO, CDMO, Qualified person (European Union), ALG, Inspection, Investment, Medtech, Biopharma LLC, List of life sciences, QP, Doctor of Philosophy, Manufacturing execution system, Leadership, TIC, Twitter, Drug discovery, Medical device, Fine chemical, Pharmacy, Element, Biotechnology, Certification, Vineta, Sustainalytics

LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, has appointed Dr. Elisabeth Lackner as Chief Scientific Officer (CSO).

Key Points: 
  • LONDON, June 30, 2022 (GLOBE NEWSWIRE) -- Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, has appointed Dr. Elisabeth Lackner as Chief Scientific Officer (CSO).
  • In the newly created CSO role, Dr. Lackner joins the Operating Board ensuring that Element is positioned at the leading-edge of scientific thinking.
  • In her new role as Chief Scientific Officer, Elisabeth will help us respond and mobilize to global trends affecting this industry, combining her scientific expertise and proven leadership skills.
  • Elisabeth will help Element to create a global platform for Life Sciences, with integrated support for the medicinal product and medical device industries.

Iovance Biotherapeutics Appoints Wendy L. Dixon, Ph.D., to Board of Directors

Retrieved on: 
Monday, June 13, 2022
Diamond, Board, Life, Marketing, PBL, University, Popular Executive Committee of Valencia, PSLRA, GlaxoSmithKline, Natural science, Food, Merck & Co., Orexigen Therapeutics, Annual report, Perception, Private Securities Litigation Reform Act, Forward-looking statement, Security (finance), Executive Committee, U.S. Securities and Exchange Commission, Organization, Cervical cancer, Risk, FDA, Therapy, BMS, Doctor of Philosophy, Patient, Dentsply Sirona, GLOBE, Bristol Myers Squibb, TIL, COVID-19, Lists of companies, Food and Drug Administration, NASDAQ, SAN, BLA, Merck, Cancer, Safety, Global marketing, Pharmaceutical industry, Medical imaging, Janssen Biotech, Iovance Biotherapeutics, Iovance Biotherapeutics, Biochemistry, West Pharmaceutical Services explosion

Phil., Chairman of the Board of Directors of Iovance, stated, Wendy has a successful track record in commercial leadership and new product launches, as well as a strong reputation for strategic thinking and executional focus.

Key Points: 
  • Phil., Chairman of the Board of Directors of Iovance, stated, Wendy has a successful track record in commercial leadership and new product launches, as well as a strong reputation for strategic thinking and executional focus.
  • Iovance is fortunate to have Wendy join our board as we prepare to submit our first BLA and transition into a fully-integrated commercial organization with a rich development pipeline.
  • I am thrilled to join the Iovance board during this important journey toward commercialization and pipeline innovation, said Dr. Dixon.
  • Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.

New Sample Preparation System Improves Proteomics Research Productivity

Retrieved on: 
Monday, June 6, 2022
Science, Software, Other Science, Biotechnology, Research, Pharmaceutical, Health, Technology, Science, Data analysis, Applied Biosystems, ASMS, Conference, Minneapolis, Research, Patheon, Society, TMT, Minneapolis Convention Center, Invitrogen, Software, American Society for Mass Spectrometry, LC-MS, Multimedia, PPD, Risk, Laboratory, Fisher Scientific, Health, Acquisition, Thermo Fisher Scientific, Mass spectrometry, West Pharmaceutical Services explosion, Mindful Scientific Inc., Proteomics, Typesetting, Fine chemical

ASMS 2022 - Thermo Fisher Scientific Inc., the world leader in serving science, is helping proteomics researchers increase productivity and free up time for more value-added activities when generating high quality samples for analysis, using a new automated sample preparation system that integrates within any LC-MS workflow.

Key Points: 
  • ASMS 2022 - Thermo Fisher Scientific Inc., the world leader in serving science, is helping proteomics researchers increase productivity and free up time for more value-added activities when generating high quality samples for analysis, using a new automated sample preparation system that integrates within any LC-MS workflow.
  • View the full release here: https://www.businesswire.com/news/home/20220606005315/en/
    Thermo Scientific AccelerOme Automated Sample Preparation Platform (Photo: Business Wire)
    The Thermo Scientific AccelerOme Automated Sample Preparation Platform eliminates the need for labor-intensive, manual sample preparation for LC-MS analysis, including the associated method development and reagent sourcing.
  • Automated sample preparation also overcomes the challenge of maintaining reproducibility with manual methodologies, and the new platforms pre-built validated methods and kit format reagents reduce further any risk of user error.
  • In research labs, sample preparation systems are necessary to help to automate complex samples and large sample sets in order to rapidly generate rigorous data for publication, and in biopharma, these systems offer speed and productivity in commercialization.

Thermo Fisher Scientific Collaborates with TransMIT GmbH on a High-Performance Orbitrap Mass Spectrometry Imaging Platform

Retrieved on: 
Monday, June 6, 2022
Technology, Research, Other Technology, Biotechnology, Hardware, Health, Pharmaceutical, Other Science, Science, Science, Biomarker, Chromatography, Mindful Scientific Inc., Applied Biosystems, ASMS, Conference, Minneapolis, Research, Patheon, Society, 3D, Mass spectrometry, Minneapolis Convention Center, Invitrogen, American Society for Mass Spectrometry, PPD, MSI, Metabolomics, Glycomics, Proteomics, Lipidomics, Technology, AF, Fisher Scientific, Laboratory, Health, Thermo Fisher Scientific, Drug development, Tissue, West Pharmaceutical Services explosion, Orbitrap, AP, Peptide, SSH File Transfer Protocol, Medical imaging

ASMS 2022 - Thermo Fisher Scientific Inc., the world leader in serving science, and TransMIT GmbH Center for Mass Spectrometric Developments have announced a co-marketing agreement to promote the use of a mass spectrometry imaging (MSI) platform for spatial multi-omics applications in pharma and clinical labs.

Key Points: 
  • ASMS 2022 - Thermo Fisher Scientific Inc., the world leader in serving science, and TransMIT GmbH Center for Mass Spectrometric Developments have announced a co-marketing agreement to promote the use of a mass spectrometry imaging (MSI) platform for spatial multi-omics applications in pharma and clinical labs.
  • This co-marketing agreement will provide integrated solutions for mass spectrometry imaging, offering a label-free approach to map the distribution of a wide range of both known and unknown compounds directly sampled from biological tissue, said Jim Yano, senior director, life sciences mass spectrometry portfolio management, chromatography and mass spectrometry, Thermo Fisher Scientific.
  • Professor Bernhard Spengler, director, TransMIT Center for Mass Spectrometric Developments, said, Our AP-SMALDI5 AF ion source coupled with Thermo Fishers Orbitrap technology create an MSI platform for high spatial resolution along with high mass resolution and mass accuracy.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion.

Expanded Liquid Chromatography-Mass Spectrometry Platform Provides All-in-One Toxicology Solution

Retrieved on: 
Monday, June 6, 2022
Technology, Research, Software, Biotechnology, Hardware, Health, Pharmaceutical, Other Science, Science, Science, ASMS, Applied Biosystems, Conference, Minneapolis, Research, Patheon, MS/MS, Society, Minneapolis Convention Center, Forensic toxicology, Invitrogen, Software, Institute of Analytical Sciences, Database, American Society for Mass Spectrometry, LC-MS, NPS, Multimedia, PPD, Library, Exploris, MS2, MS, Fisher Scientific, Laboratory, Health, LC, Acquisition, Thermo Fisher Scientific, Fentanyl, Toxicology, Mass spectrometry, LGC, Illegal drug trade, The Explorers (collection), Plasma protein binding, West Pharmaceutical Services explosion, Mindful Scientific Inc., Running, Fine chemical, Typesetting, Medical device

This toxicology solution offers a standardized method with LC retention times that allows users to get up and running fast.

Key Points: 
  • This toxicology solution offers a standardized method with LC retention times that allows users to get up and running fast.
  • This solution comes complete with the software, service and support to sustain laboratory productivity.
  • Overall, the Tox Explorer Collection for Orbitrap Exploris 120 MS provides a powerful solution for forensic toxicology.
  • Thermo Scientific Orbitrap Exploris 120 MS provides ultra-high-resolution MS, HRAM specificity and polarity switching for fast, accurate and reportable results.

Updated Software Solutions Offer Increased Productivity and Data Confidence

Retrieved on: 
Monday, June 6, 2022
Technology, Research, Software, Biotechnology, Health, Pharmaceutical, Data Management, Other Science, Science, Science, Table, Chromatography, Data analysis, ASMS, Applied Biosystems, Conference, Minneapolis, Research, Patheon, Society, Mass spectrometry, Minneapolis Convention Center, Proteomics, Invitrogen, Software, American Society for Mass Spectrometry, Intelligence, PPD, Metabolomics, MSN, Compound, Laboratory, Fisher Scientific, Review, Health, Acquisition, Thermo Fisher Scientific, Food safety, West Pharmaceutical Services explosion, Mindful Scientific Inc., Oligonucleotide, Fine chemical

The latest software updates bring new features that enable researchers to extract more information from their new and existing data, streamline data interpretation, and standardize reporting with increased ease of use.

Key Points: 
  • The latest software updates bring new features that enable researchers to extract more information from their new and existing data, streamline data interpretation, and standardize reporting with increased ease of use.
  • Thanks to the latest upgrades to our software suites, we can give scientists access to the newest technologies and built-for-purpose platforms to quickly and confidently turn data into meaningful results.
  • Improved data review tools and tables offer streamlined review and results reporting of complex oligonucleotide data sets.
  • This deeper mining of data expands the ways in which proteomics scientists can acquire and apply their data.

Novel Mass Spectrometry Solution Simplifies Insight Gathering into Macromolecular Complexes

Retrieved on: 
Monday, June 6, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, Hardware, Health, Technology, Science, Biochemistry, Â, ASMS, Applied Biosystems, Proteome, Minneapolis, Patheon, Research, Society, Conference, Ion, Mass spectrometry, Minneapolis Convention Center, Invitrogen, American Society for Mass Spectrometry, Solution, Multimedia, PPD, Proteoform, Laboratory, Fisher Scientific, Technology, Health, Protalix BioTherapeutics, Thermo Fisher Scientific, Drug discovery, West Pharmaceutical Services explosion, Mindful Scientific Inc., Proteomics, Fine chemical, Northwestern University

View the full release here: https://www.businesswire.com/news/home/20220606005311/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220606005311/en/
    Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers (Photo: Business Wire)
    The Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities, allowing direct mass determination of hundreds to thousands of individual ions in a single spectrum.
  • As a result, laboratories can measure mass for complex heterogeneous mixtures of multiple charged components, unlocking new and rich insights into proteoforms, biotherapeutics and next-generation drug modalities.
  • Direct Mass Technology mode combines charge detection with our trusted high-resolution accurate mass Orbitrap measurements to achieve results unattainable by current ensemble measurement techniques, said Iain Mylchreest, vice president, research and development, analytical instruments, Thermo Fisher Scientific.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion.

Advanced HPLC Column Delivers Improved Separation Performance and Protein Identification in Comprehensive New Proteomics Workflow

Retrieved on: 
Monday, June 6, 2022
Health, Other Science, Research, Pharmaceutical, Science, Biotechnology, Remco, Science, ASMS, Applied Biosystems, Conference, Minneapolis, Research, Patheon, Marketing, Society, IMP, Minneapolis Convention Center, Invitrogen, American Society for Mass Spectrometry, Research institute, LC-MS, Multimedia, PPD, Workflow, Peptide, MS, Laboratory, Fisher Scientific, Technology, Health, Thermo Fisher Scientific, Mass spectrometry, West Pharmaceutical Services explosion, Mindful Scientific Inc., Proteomics, Protein, Fine chemical, Typesetting

This helps users accelerate their experimental setup with the reassurance of high-level performance across every component of the workflow.

Key Points: 
  • This helps users accelerate their experimental setup with the reassurance of high-level performance across every component of the workflow.
  • The new column delivers exceptional separation performance over a wide range of flow rates, offering the ultra-high resolution needed to extract maximum information from complex samples.
  • Proteomics researchers are demanding ever-greater sample coverage and improved protein identification to effectively advance their research.
  • The Thermo Scientific PAC Neo HPLC Column overcomes these challenges by pairing powerful separation capabilities with dependable column-to-column reproducibility.

Thermo Fisher Scientific Releases Corporate Social Responsibility Report

Retrieved on: 
Thursday, June 2, 2022
Other Philanthropy, Science, Other Science, Philanthropy, Research, Science, Paris Agreement, Value, Goal, Applied Biosystems, Paris, Research, Patheon, CDP, ESG, TMO, United Nations, Corporate social responsibility, Invitrogen, STEM, Sustainable Development Goals, Environment, Global, Multimedia, PPD, Student, Technology, Fisher Scientific, Laboratory, Health, CSR, NYSE, Thermo Fisher Scientific, Task force, GRI, Culture, Engineering, West Pharmaceutical Services explosion, Mindful Scientific Inc., Central Vermont Community Action Council, Sustainability, Management, Renewable energy

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report.

Key Points: 
  • Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report.
  • The report highlights the companys commitment to society and stakeholders providing detailed insight into the companys CSR progress and environmental, social and governance (ESG) efforts.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion.
  • Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

The Phadia 2500+ Instrument Family Now Available in the U.S. for Autoimmune Testing

Retrieved on: 
Thursday, May 26, 2022
Other Health, Research, General Health, Pharmaceutical, Medical Devices, Hospitals, Genetics, Science, Biotechnology, Medical Supplies, Other Science, Health, Connective tissue disease, Thermo Fisher Scientific, Family, Autoimmunity, Applied Biosystems, Degenerative disease, Science, Patheon, PPD, Health, Automation, Coeliac disease, Rheumatoid arthritis, CTD, Research, Fisher Scientific, Immunoassay, Antiphospholipid syndrome, Elia, APS, Invitrogen, Mindful Scientific Inc., Diagnosis, Laboratory, West Pharmaceutical Services explosion, Medical device, Phadia

The new Phadia 2500+ series of instruments is now available for autoimmune testing in the U.S.

Key Points: 
  • The new Phadia 2500+ series of instruments is now available for autoimmune testing in the U.S.
  • The family of high-capacity, intuitive lab instruments supplied by Thermo Fisher Scientific, the world leader in serving science, offers reliable and unparalleled high throughput for both allergy diagnostics and autoimmune testing.
  • This expanded capability of the Phadia 2500+ series of instruments allows for instrument consolidation and enables additional automation for EliA autoimmune diagnostics, aiding in the diagnosis of autoimmune diseases including Connective Tissue Disease (CTD), Antiphospholipid Syndrome (APS), Celiac Disease, Rheumatoid Arthritis, Autoimmune Liver Disease and Autoimmune Thyroid Disease.
  • The series of instruments includes the Phadia 2500 (ImmunoCAP analyzer), Phadia 2500EE (EliA analyzer) and Phadia 2500E (ImmunoCAP and EliA analyzer).